Corneal ulceration associated with dupilumab use in a patient with atopic dermatitis
Open Access
- 1 September 2020
- journal article
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 19, 100848
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Context-Dependent Regulation of Conjunctival Goblet Cell Function by Allergic MediatorsScientific Reports, 2018
- Dupilumab: A review of its use in the treatment of atopic dermatitisJournal of the American Academy of Dermatology, 2018
- In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virusScientific Reports, 2018
- Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical tBritish Journal of Dermatology, 2017
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trialThe Lancet, 2017
- Dupilumab: First Global ApprovalDrugs, 2017
- Review of Atopic Dermatitis and Topical TherapiesJournal of Cutaneous Medicine and Surgery, 2016
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic DermatitisNew England Journal of Medicine, 2016
- Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trialThe Lancet, 2016
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic DermatitisNew England Journal of Medicine, 2014